Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
0.5754
-0.0054 (-0.93%)
At close: Oct 8, 2025, 4:00 PM EDT
0.5842
+0.0088 (1.53%)
After-hours: Oct 8, 2025, 7:24 PM EDT
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of $6.01 million as of October 8, 2025. Its market cap has decreased by -58.00% in one year.
Market Cap
6.01M
Enterprise Value
130.67K
1-Year Change
-58.00%
Ranking
Category
Stock Price
$0.58
Market Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from $4.97M to $6.01M, an increase of 20.90%. That is a compound annual growth rate of 1.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2025 | 6.01M | -45.73% |
| Dec 31, 2024 | 11.07M | -48.88% |
| Dec 31, 2023 | 21.67M | -19.15% |
| Dec 29, 2022 | 26.80M | -60.87% |
| Dec 30, 2021 | 68.47M | 2.08% |
| Dec 31, 2020 | 67.08M | 364.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |